Medicines called proton pump inhibitors, or PPIs, are used by millions of people around the world to treat common stomach problems.
These problems include heartburn, acid reflux, and a long-term condition called gastroesophageal reflux disease, also known as GERD.
Many people take these medicines every day to reduce burning pain in the chest and to feel more comfortable after eating. Some well-known brands include Prilosec, Nexium, and Prevacid. In the United States alone, about one in ten adults uses these drugs.
PPIs work by lowering the amount of acid made in the stomach. This helps protect the lining of the stomach and the food pipe, which can become irritated by strong stomach acid. For many people, these drugs are very helpful and improve their quality of life.
However, new research suggests that these medicines may not be as harmless as once thought, especially when it comes to kidney health.
A research team from the University of California San Diego carried out a large study to better understand the possible risks linked to these drugs. The findings were based on data from the FDA Adverse Event Reporting System, often called FAERS.
This is a large database that collects reports from patients and doctors about side effects linked to medicines. It includes millions of records from people who have experienced health problems while taking different drugs.
To make their study clear and focused, the researchers looked at about 43,000 people who took PPIs only, without mixing them with other medicines. This helped them better understand the effects of PPIs alone.
They also compared this group with about 8,000 people who took a different type of medicine for heartburn called histamine-2 receptor antagonists, or H2 blockers. These drugs, such as Zantac and Pepcid, reduce stomach acid in a different way and are often used as an alternative to PPIs.
The results showed a clear and worrying pattern. About 5.6 percent of people who took PPIs reported kidney-related problems. In contrast, only 0.7 percent of people who took H2 blockers reported similar issues. This difference suggests that people using PPIs may have a higher risk of kidney problems.
When the researchers looked more closely, they found that people taking PPIs were much more likely to report serious kidney conditions. These included chronic kidney disease, which is a long-term loss of kidney function, and acute kidney injury, which is a sudden and serious decline in kidney health.
The risk of chronic kidney disease was more than 28 times higher in the PPI group compared to the H2 blocker group. The risk of end-stage kidney disease, which is a very severe condition that may require dialysis or a transplant, was also much higher.
The study also found that people taking PPIs had more problems with electrolyte balance. Electrolytes are important minerals in the body that help control fluid levels and support many body functions, including how the kidneys work. When these levels are not balanced, it can affect overall health.
Interestingly, the risk of kidney problems was seen across different types of PPIs, meaning the effect was not limited to just one specific drug. This suggests that the risk may be linked to how PPIs work in general, rather than a problem with a single brand.
This study adds to growing concerns about the long-term safety of PPIs. In fact, earlier research published in 2017 by the UC San Diego School of Medicine suggested that these drugs may also increase the risk of chronic liver disease. This raises the possibility that PPIs could affect more than one organ over time.
Despite these risks, PPIs are still considered important medicines by health organizations such as the World Health Organization. They provide strong relief for people with severe acid-related problems.
However, the researchers believe that patients and doctors should be more aware of the possible risks, especially for people who already have kidney problems or are at higher risk.
The study was published based on data from the FDA Adverse Event Reporting System and highlights the need for careful use of these medicines. Patients should not stop taking their medication without talking to a doctor, but they may want to ask if other options are suitable. Regular health check-ups, including kidney function tests, can also help detect problems early.
In the future, more research will likely explore how these drugs affect the body over long periods. For now, this study reminds us that even common medicines can have hidden risks, and it is important to use them wisely and stay informed about their effects.
If you care about kidney health, please read studies about drug that prevents kidney failure in diabetes, and drinking coffee could help reduce risk of kidney injury.
For more information about kidney health, please see recent studies about foods that may prevent recurrence of kidney stones, and common painkillers may harm heart, kidneys and more.
Copyright © 2026 Knowridge Science Report. All rights reserved.
